Codagenix is a series b startup based in United States. 1 investor tracked.
Based in the United States, Codagenix is a startup founded in 2014. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
prophylactic vaccines and oncolytic virus therapies
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.